90.14USD-2.32%Mkt Cap: 53.13B $P/E: 54.93Today
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement prod…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap53.13B $
Enterprise Value48.34B $
Revenue (TTM)6.51B $
Gross Profit4.73B $
Net Income (TTM)1.07B $
Revenue/Share11.22 USD
Last Price90.14 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees16.0K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS28176E1082
Valuation
P/E (Trailing)54.93
P/E (Forward)26.61
PEG2.22
EV/EBITDA24.21
EV/Revenue7.42
P/S7.95
P/B4.88
EPS (TTM)1.63
EPS (Forward)3.38
52W Range
72.3074% of range96.29
52W High96.29 USD
52W Low72.30 USD
Profitability
Gross Margin78.01%
Oper. Margin29.84%
EBITDA Margin30.66%
Profit Margin17.69%
ROE10.38%
ROA7.84%
Growth
Revenue Growth13.60%
Earnings Growth-25.40%
Cash Flow & Leverage
Operating CF1.60B $
CapEx (TTM)260.20M $
FCF Margin18.92%
FCF Yield2.32%
Net Debt-3.55B $
Net Debt/EBITDA-1.78
Balance Sheet
Debt/Equity0.07
Current Ratio4.52
Quick Ratio3.45
Book Value/Sh18.41 USD
Cash/Share7.378 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split3:1
Split DateJun 1, 2020
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)100.96 USD
Upside (mean)+12.0%
Target Range84.00 USD – 110.00 USD
$84.00+12.0% to mean$110.00
# Analysts26
Ownership
Shares Out.575.80M
Float574.49M
Insiders0.19%
Institutions97.11%
Short Interest
Short Ratio2.0d
Short % Float1.98%
Short % Out.1.74%
Shares Short10.04M
Short (prev mo.)11.47M
Technical
SMA 5088.91 (+1.4%)
SMA 20084.62 (+6.5%)
Beta0.85
S&P 52W Chg18.16%
Avg Vol (30d)3.60M
Avg Vol (10d)2.91M
Technical Indicators
RSI (14)60.0
MACD1.2548
MACD Signal0.8385
MACD Hist.+0.4163
BB Upper95.71 USD
BB Middle88.44 USD
BB Lower81.16 USD
BB Width16.46%
ATR (14)2.202 USD
Vol Ratio (20d)0.66x